Lion Plans to Halt Revenue Free-Fall with Accelerated Product Development Schedule | GenomeWeb

Lion Bioscience last week reported a 33 percent drop-off in revenues for its 2003/2004 fiscal year ended March 31, 2004, and says that the slide will continue through the end of this year. But the company sees a light at the end of the tunnel, as it is projecting double-digit growth in FY 2005/2006 based on a ramped-up product-launch roadmap that will get underway this summer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.